Lyme Disease: Diagnosis and Treatment for People and Pets

Bad Reactions to Cosmetics? Tell FDA!

Medical Device Quality Management System Regulation Risk Management

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

FDA Direct: Removing Black Box Warnings for HRT (Part 1/2)

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S08 – Symposium Wrap-up and...

Healthier Choices Made Easier: Proposed Front-of-Package Nutrition Info Box

FDA Expert Panel on Testosterone Replacement Therapy for Men

November 13, 2025: Pediatric Advisory Committee Meeting (PAC)

Medical Device Quality Management System Regulation Design and Development

Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S07 – Q&A Discussion Panel

FDA Direct: Removing Black Box Warnings for HRT (Part 2/2)

Tobacco Products Scientific Advisory Committee Meeting, October 7, 2025

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S04 - (PV): International...

Healthy Breakfasts for Kids

Public Meeting: Reauthorization of the Biosimilar User Fee Act

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S05 - (PV): Future of...

GCP & Pharmacovigilance Compliance Symposium | D3S03-1 - (BE): Clinical Study Conduct

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S03-2 – Q&A Discussion Panel

FDA Direct: FDA Awards Six National Priority Vouchers